Therapeutic Benefit Suppliers In North America

The exponential growth of biomedical data, driven by the adoption of electronic medical records (EMRs), provides an unprecedented opportunity to create transformative technologies and products in healthcare. nference partners with medical centers to ...

AxioBionics is a leader in the development and implementation of advanced medical devices designed to improve the quality of life for individuals with musculoskeletal and nervous system disorders. The company focuses on harnessing the innate ...

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...

We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) ...

We provide the essential products, technologies and expertise to produce biopharmaceuticals reliably and efficiently. In fact, Sartorius has been pioneering and setting the standards for single-use products that are currently used throughout all ...

N8 Medical, LLC (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins. These proprietary ceragenin compounds impart unique properties ...

We are Hyper-accelerate drug and medical device development. Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to ...

TVAX Biomedical is a clinical stage development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. TVAX Biomedical is developing a paradigm-shifting cancer treatment that offers the promise of improved ...

NanoVibronix develops innovative ultrasound therapy devices based on its proprietary therapeutic ultrasound technology. Our products employ small, disposable transducers that transmit low frequency, low intensity ultrasound acoustic waves. These ...

JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers. JSR ...

Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells. To ...

We are Canadian designers and manufacturers of ozone generator kits for use at home and clinics, ozone sauna cabinets and ozone steam sauna systems. Recover U sauna is the newest state of the art ozone steam sauna and is the most complete system in ...

Bio-Tissue, Inc. was founded in 1997 to help address unmet needs for improved surgical and therapeutic alternative to treat ocular surface conditions; one that would serve as a non-immunogenic tissue replacement and would help facilitate tissue ...

POP Biotechnologies, Inc. (POP BIO) is dedicated to addressing critical medical challenges with advanced nanotechnologies. POP BIO’s key breakthrough, the porphyrin-phospholipid (PoP) platform, facilitates the creation of powerful light-targeted ...

CervoMed is a clinical stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as ...

Dyve Biosciences created a breakthrough transdermal delivery platform that overturns the traditional limitations of administering therapies and allows for drug development across therapeutic areas. Our proprietary platform science can be applied to ...

Kaio's strategy is to develop and in-license technologies and therapies that enable the body’s own immune system to work more efficiently. The goal is to improve clinical outcomes for patients, increase the number and efficacy of therapeutic options ...

LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...

Bioness is the leading provider of innovative technologies helping people regain mobility and independence. Bioness solutions include functional electrical stimulation (FES) systems, robotic systems and software based therapy programs providing ...

Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...